Capecitabine plus pembrolizumab in patients with triple negative breast cancer after chemoimmunotherapy and surgery

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2025
This article has no abstract
Epistemonikos ID: 242e94ba703ff8e0b2c3ded65f1c40efa9e2b3ec
First added on: Jan 16, 2026